Total Payments
$1,182
2024 Payments
$94.81
Companies
10
Transactions
37
Medicare Patients
2,530
Medicare Billing
$510,862
Payment Breakdown by Category
Food & Beverage$1,010 (85.5%)
Education$171.18 (14.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,010 | 34 | 85.5% |
| Education | $171.18 | 3 | 14.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $352.26 | 8 | $0 (2018) |
| Allergan Inc. | $240.17 | 8 | $0 (2018) |
| Merck Sharp & Dohme LLC | $216.91 | 10 | $0 (2024) |
| Gilead Sciences Inc | $198.33 | 2 | $0 (2017) |
| ABBVIE INC. | $61.47 | 3 | $0 (2024) |
| ViiV Healthcare Company | $40.36 | 2 | $0 (2020) |
| ConvaTec Inc. | $21.44 | 1 | $0 (2024) |
| Shionogi Inc | $21.15 | 1 | $0 (2023) |
| Insmed, Inc. | $16.24 | 1 | $0 (2022) |
| Theravance Biopharma, Inc. | $13.21 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $94.81 | 4 | ABBVIE INC. ($48.47) |
| 2023 | $155.74 | 6 | Merck Sharp & Dohme LLC ($134.59) |
| 2022 | $16.24 | 1 | Insmed, Inc. ($16.24) |
| 2020 | $18.87 | 1 | ViiV Healthcare Company ($18.87) |
| 2018 | $548.83 | 20 | Allergan Inc. ($240.17) |
| 2017 | $347.05 | 5 | Gilead Sciences Inc ($198.33) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/24/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $31.91 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/12/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/09/2024 | ConvaTec Inc. | AQUACEL AG+ (Device) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 03/26/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/07/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Infections and Infectious Diseases | ||||||
| 10/11/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/21/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $32.20 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/13/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/08/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $32.38 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/08/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/05/2022 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 07/17/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: HIV | ||||||
| 12/11/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/31/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/24/2018 | Astellas Pharma US Inc | MYCAMINE (Drug), CRESEMBA | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/26/2018 | ViiV Healthcare Company | TRIUMEQ (Drug), JULUCA | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: HIV | ||||||
| 08/08/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/25/2018 | Astellas Pharma US Inc | CRESEMBA (Drug), AMBISOME, MYCAMINE | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 06/27/2018 | Theravance Biopharma, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Infectious Disease | ||||||
| 06/20/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/18/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $84.99 | General |
| 06/18/2018 | Astellas Pharma US Inc | — | Education | In-kind items and services | $69.95 | General |
| 06/06/2018 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), ZEPATIER | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/16/2018 | Astellas Pharma US Inc | CRESEMBA (Drug), MYCAMINE, AMBISOME | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/15/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $59.25 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 822 | 1,581 | $483,024 | $146,909 |
| 2022 | 10 | 785 | 1,947 | $517,469 | $180,231 |
| 2021 | 5 | 628 | 1,447 | $313,782 | $126,916 |
| 2020 | 6 | 295 | 607 | $136,682 | $56,806 |
Total Patients
2,530
Total Services
5,582
Medicare Billing
$510,862
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 230 | 737 | $190,146 | $66,487 | 35.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 134 | 137 | $68,363 | $18,198 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 124 | 170 | $54,400 | $14,719 | 27.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 22 | 85 | $59,925 | $14,678 | 24.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 88 | 217 | $38,843 | $13,382 | 34.5% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 76 | 76 | $19,456 | $4,983 | 25.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 37 | $16,798 | $4,491 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 47 | $10,716 | $3,050 | 28.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $10,062 | $3,017 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $5,922 | $1,651 | 27.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $4,433 | $1,151 | 26.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 29 | 30 | $3,960 | $1,103 | 27.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 294 | 1,261 | $285,660 | $103,473 | 36.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 198 | 201 | $87,010 | $31,192 | 35.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 22 | 83 | $54,595 | $13,336 | 24.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 70 | 179 | $27,290 | $10,327 | 37.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 85 | $24,394 | $8,521 | 34.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 41 | 41 | $13,780 | $4,455 | 32.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 25 | $9,985 | $3,629 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 42 | $8,361 | $3,042 | 36.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $4,396 | $1,622 | 36.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 18 | 18 | $1,998 | $635.14 | 31.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 216 | 719 | $148,814 | $60,337 | 40.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 211 | 218 | $87,603 | $35,235 | 40.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 155 | 453 | $65,220 | $26,451 | 40.6% |
About Dr. Jacobo Leon, MD
Dr. Jacobo Leon, MD is a Infectious Disease healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2012. The National Provider Identifier (NPI) number assigned to this provider is 1972863629.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacobo Leon, MD has received a total of $1,182 in payments from pharmaceutical and medical device companies, with $94.81 received in 2024. These payments were reported across 37 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,010).
As a Medicare-enrolled provider, Leon has provided services to 2,530 Medicare beneficiaries, totaling 5,582 services with total Medicare billing of $510,862. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Other Specialties Infectious Disease
- Location Augusta, GA
- Active Since 05/29/2012
- Last Updated 01/16/2025
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1972863629
Products in Payments
- AVYCAZ (Drug) $260.51
- Genvoya (Drug) $198.33
- DIFICID (Drug) $159.49
- CRESEMBA (Drug) $45.56
- ZERBAXA (Drug) $30.58
- DALVANCE (Drug) $28.13
- ISENTRESS (Drug) $26.84
- Cresemba (Drug) $23.33
- TRIUMEQ (Drug) $21.49
- AQUACEL AG+ (Device) $21.44
- Fetroja (Drug) $21.15
- DOVATO (Drug) $18.87
- Arikayce (Drug) $16.24
- MYCAMINE (Drug) $16.04
- VIBATIV (Drug) $13.21
- Mavyret (Drug) $13.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Augusta
Cheryl Newman, Md, MD
Infectious Disease — Payments: $150,138
Infectious Disease $150,138
John Rissing, Md, MD
Infectious Disease — Payments: $43,837
Infectious Disease $43,837
Dr. Jack Austin, Md, MD
Infectious Disease — Payments: $7,058
Infectious Disease $7,058
Dr. Francisco Hernandez Munoz, M.d, M.D
Infectious Disease — Payments: $4,252
Infectious Disease $4,252
Dr. Andrew Chao, M.d, M.D
Infectious Disease — Payments: $4,005
Infectious Disease $4,005
Dr. Kepler Davis, M.d, M.D
Infectious Disease — Payments: $3,326
Infectious Disease $3,326